Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base

被引:0
|
作者
Amy C. Moreno
Waqar Haque
Vivek Verma
Penny Fang
Steven H. Lin
机构
[1] University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] Houston Methodist Hospital,Department of Radiation Oncology
[3] University of Nebraska Medical Center,Department of Radiation Oncology
来源
关键词
National Cancer Data Base (NCDB); Propensity Matching; Non-small Cell Lung Cancer (NSCLC); Relative Toxicity Factor; Indication Bias;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1245 / 1253
页数:8
相关论文
共 50 条
  • [1] Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
    Krantz, Seth B.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1473 - 1474
  • [2] Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
    Seth B. Krantz
    Annals of Surgical Oncology, 2018, 25 : 1473 - 1474
  • [3] Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
    Moreno, Amy C.
    Haque, Waqar
    Verma, Vivek
    Fang, Penny
    Lin, Steven H.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1245 - 1253
  • [4] Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer
    Verma, Vivek
    Moreno, Amy C.
    Haque, Waqar
    Fang, Penny
    Lin, Steven H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 508 - 516
  • [5] A Propensity-Matched Analysis of Neoadjuvant Chemoradiotherapy and Adjuvant Chemoradiotherapy for IIIA(N2) Non-Small Cell Lung Cancer
    Zhu, Y.
    Jiang, C.
    Chen, Y.
    Liu, J.
    Xu, Y.
    Chen, Q.
    Mao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S852 - S853
  • [6] Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
    Kim, Hwan-Ik
    Noh, O. Kyu
    Oh, Young-Taek
    Chun, Mison
    Kim, Sang-Won
    Cho, Oyeon
    Heo, Jaesung
    RADIATION ONCOLOGY JOURNAL, 2016, 34 (03): : 202 - 208
  • [7] Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients
    Li, Xiao
    Zhang, Chao
    Sun, Zewen
    Yang, Fan
    Xiao, Rongxin
    Sui, Xizhao
    Jiang, Guanchao
    Zhong, Wenzhao
    Wang, Jun
    LUNG CANCER, 2019, 133 : 75 - 82
  • [8] Radiotherapy for patients with completely resected pathologic IIIA(N2) non-small-cell lung cancer: a retrospective analysis
    Zhu, Ying
    Fu, Lei
    Jing, Wang
    Kong, Li
    Yu, Jinming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10901 - 10908
  • [9] Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis
    Mantovani, Cristina
    Levra, Niccolo Giaj
    Filippi, Andrea R.
    Novello, Silvia
    Buffoni, Lucio
    Ragona, Riccardo
    Ricardi, Umberto
    CLINICAL LUNG CANCER, 2013, 14 (02) : 194 - 199
  • [10] Clinical Efficacy of Postoperative Radiotherapy for High Risk Locoregional Recurrence in Patients with Completely Resected Pathologic Stage IIIA(N2) Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis
    Zhang, S.
    Hou, R.
    Cai, X.
    Liu, J.
    Yu, W.
    Zhang, Q.
    Guo, J.
    Zhu, Z.
    Feng, W.
    Fu, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E20 - E20